<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-64198</identifier>
<setSpec>0214-9168</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:description xml:lang="en">Introduction. We have studied the effect of 3 model diets on glucose and insulin response, lipid profile and endothelial function in insulin resistant subjects. Patients and methods. Eleven volunteers with insulin resistance and central overweight underwent 3 phases of diet on weight-maintenance, in a randomized and crossed study: a rich-saturated fat diet (SAT), another one rich in monounsaturated fat (MUFA, rich in olive oil) and another rich in carbohydrates (CH). We determined the glucose and insulin levels, the lipid profile and the half-full flow mediated endothelial vasodilation by means of Laser-Doppler. Results. Body weight and basal energy expenditure were unchanged throughout the study. The homeostasis model assessment-insulin resistance (HOMA-ir) was improved during the MUFA-rich diet as compared with SAT and CH diets (2.32 ± 0.35; 2.72 ± 0.37 and 2.52 ± 0.37; p &lt; 0.05). During a CH rich breakfast, postprandial glucose, insulin and nitrotyrosine levels were increased and the HDL-C levels remained lowered as compared with those during MUFA and SAT diets. Endothelial reactivity, measured fasting and after 150 min of meal test, was higher with olive oil rich diet compared with SAT and CH rich diets (baseline values: 271.1 ± 16.63, 220.8 ± 13.6, 244.9 ± 37.7, ANOVA p &lt; 0.05; postprandial values: 251.9 ± 16.3, 180.1 ± 10.6, 181.4 ± 16, ANOVA p &lt; 0.05). Conclusions. In insulin resistant subjects a MUFA-rich diet improves HOMA-ir, decreases postprandial glucose, insulin and nitrotyrosine levels, increases HDL-C levels and improves basal and postprandial endothelial reactivity (AU)</dc:description>
<dc:creator>Valverde-Estepa, Araceli</dc:creator>
<dc:creator>Pérez-Jiménez, Francisco</dc:creator>
<dc:creator>Fuentes, Francisco</dc:creator>
<dc:creator>Ruano, Juan</dc:creator>
<dc:creator>Romero, M. Inmaculada</dc:creator>
<dc:creator>Sánchez, M. Esther</dc:creator>
<dc:creator>Paniagua, Juan A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. Hemos estudiado el efecto de 3 modelos de dieta en la respuesta de glucosa e insulina, el perfil lipídico y la función endotelial en individuos con resistencia a la insulina. Pacientes y métodos. Once voluntarios con sobrepeso abdominal y resistencia a la insulina realizaron 3 fases de dieta en mantenimiento de peso, en un estudio aleatorizado y cruzado: una rica en grasas saturadas (SAT), otra en grasas monoinsaturadas (MUFA) y otra en hidratos de carbono (HC). Hemos determinado los valores de glucosa e insulina, el perfil lipídico y la vasodilatación endotelial mediada por el flujo con láser Doppler. Resultados. El peso corporal y el gasto energético basal no cambiaron durante las 3 fases de la dieta. El homeostasis model assessment-insulin resistance (HOMA-ir) mejoró tras la dieta rica en MUFA, comparada con las dietas altas en SAT e HC (2,32 ± 0,35; 2,72 ± 0,37, y 2,52 ± 0,37; p &lt; 0,05). Un desayuno rico en HC incrementa los valores posprandiales de glucosa, insulina y nitrosamina, y disminuye los valores de colesterol unido a lipoproteínas de alta densidad (cHDL) comparados con las dietas MUFA y SAT. La reactividad endotelial en ayuno y posprandial tras 150 min de la ingesta fue mayor con MUFA, comparada con las dietas ricas en SAT y en HC (271,1 ± 16,63; 220,8 ± 13,6; 244,9 ± 37,7; p &lt; 0,05; y 251,9 ± 16,3; 180,1 ± 10,6; 181,4 ±16; ANOVA; p &lt; 0,05, respectivamente). Conclusiones. En pacientes con resistencia a la insulina, una dieta alta en MUFA mejora el HOMA-ir, disminuye los valores posprandiales de glucosa, insulina y nitrosamina, incrementa los valores de cHDL y mejora la reactividad endotelial (AU)</dc:description>
<dc:source>Clín. investig. arterioscler. (Ed. impr.);20(2): 55-63, mar. 2008. ilus, tab</dc:source>
<dc:identifier>ibc-64198</dc:identifier>
<dc:subject>^d^s22000</dc:subject>
<dc:subject>^d22231^s22031</dc:subject>
<dc:subject>^d28620</dc:subject>
<dc:subject>^d1812^s22002</dc:subject>
<dc:subject>^d22182^s22031</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d2898^s22045</dc:subject>
<dc:subject>^d1860^s22031</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d25123</dc:subject>
<dc:subject>^d23101^s22073</dc:subject>
<dc:subject>^d4074^s22045</dc:subject>
<dc:subject>^d22231^s22038</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d6091^s22002</dc:subject>
<dc:subject>^d10936^s22002</dc:subject>
<dc:subject>^d15077</dc:subject>
<dc:type>article</dc:type>
<dc:date>200803</dc:date>
</metadata>
</record>
</ibecs-document>
